DLEC1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DLEC1 monoclonal antibodies for research applications. DLEC1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DLEC1, or Deleted in Lung Cancer 1, functions as a tumor suppressor and influences cell adhesion and migration. DLEC1 expression shows reduced levels across multiple cancer types, making it a significant focus in cancer research and therapeutic development. Understanding DLEC1's role can reveal important aspects of cancer progression and metastasis. Researchers can utilize DLEC1 monoclonal antibodies to examine protein localization within cellular structures. Advanced visualization techniques with DLEC1 monoclonal antibodies enable detailed analysis of protein expression patterns in normal and diseased tissues. DLEC1 monoclonal antibodies support precise protein detection, helping researchers advance scientific understanding of cancer biology and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing cancer research by providing reliable tools for studying tumor suppressor mechanisms.